9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema. - Wikidata - awgldk - TriplyDB

9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema.

9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema.

http://www.wikidata.org/entity/Q35890872

about

Induction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoids Intravital Imaging Reveals Dynamics of Lymphangiogenesis and Valvulogenesis.Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity Topical tacrolimus for the treatment of secondary lymphedema.Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration.Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel The feasibility of a fiber optic laser approach to relieving lymphedematous syndrome: a case report.NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells Role of bone marrow-derived lymphatic endothelial progenitor cells for lymphatic neovascularization.Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.Postnatal Chick Choroids Exhibit Increased Retinaldehyde Dehydrogenase Activity During Recovery From Form Deprivation Induced Myopia New developments in clinical aspects of lymphatic disease.Lymphatic vessels: new targets for the treatment of inflammatory diseases.Lymphangiogenesis in renal diseases: passive bystander or active participant?Experimental lymphedema: can cellular therapies augment the therapeutic potential for lymphangiogenesis?Lymphangiogenesis: a potential new therapy for lymphedema?Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.Design principles for lymphatic drainage of fluid and solutes from collagen scaffolds.Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model.

P2860

Q26995750-1654F4A1-5A16-47B5-AE4D-C5367E6F8C57 Q27301422-A42A30DC-03F6-4607-803D-A68EDAC2A7B7 Q28244698-3109FBCC-1A52-449C-B60B-AC221AD347C5 Q30838687-B22371BF-0824-4B85-820D-5E14D66E9806 Q34199527-E4F132F7-A00E-45F4-A0DE-1F0C1CD80F28 Q34525884-CA8B0D90-A2EF-431B-ADAF-3FDC345139AE Q34593435-9C41AD9B-529D-4832-80EC-CE1C7B89E58F Q35067960-5FD86742-BB62-46F9-9E21-4E65233EEC70 Q35853477-1F2B5F41-58F4-42FC-BBA2-48C15316AFC1 Q36046822-098937F6-16C2-4F97-BE18-9272A7701E7D Q36062311-42043393-45F1-4F94-B553-E6EFC0DDA33E Q36405877-EC58C49A-BA7E-49DD-B583-9E7B1F6A00E5 Q37275308-FC4FBDFB-E579-4AA2-BC9C-5C8160A0EDD3 Q37609636-7AC673F9-EF64-48FB-8EA1-E7AF3D11675F Q38161374-48F5303E-3ED5-4565-850C-0AB1905EFCAA Q38254023-B11665B1-AF7C-4F00-8D62-FF4C50F51445 Q41545921-19D0DBAD-8D68-4AD8-BCA5-021DB59AE2C3 Q43180251-E8BB0A24-B7F0-4D74-9655-FCB1DE54DDE6 Q46320990-BB5D806C-29D5-453A-B628-2E4CC88512A7 Q47706857-DD3AFEB1-AE72-40DC-B42B-53623825C308 Q50250425-6A758730-A49D-4A85-A989-6E82770BE33C

P2860

9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema.

http://www.wikidata.org/entity/Q35890872

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

9-cis retinoic acid promotes l ...... acid for secondary lymphedema.

@ast

9-cis retinoic acid promotes l ...... acid for secondary lymphedema.

@en

type

label

9-cis retinoic acid promotes l ...... acid for secondary lymphedema.

@ast

9-cis retinoic acid promotes l ...... acid for secondary lymphedema.

@en

prefLabel

9-cis retinoic acid promotes l ...... acid for secondary lymphedema.

@ast

9-cis retinoic acid promotes l ...... acid for secondary lymphedema.

@en

P1433

Q35890872-4B373168-D254-49F8-AEE6-FAD55F058D34

P1476

Q35890872-37FB8D44-C2E5-475F-BC14-0284CB137134

P2093

Q35890872-18BA2809-ED17-45D9-A2C2-82B0DBD447FA

Q35890872-1F6878E5-1F80-4761-B10D-D132ABB656C2

Q35890872-24D61CB6-FABB-4047-8076-E4FD99D417DD

Q35890872-3052D5EC-10FE-4238-A241-06D5C66AC9D6

Q35890872-370CAEAF-8FFF-4A22-A920-DB707C49AF82

Q35890872-45BB4EB0-F42A-4310-822C-C92F9671EB29

Q35890872-5C9C55AE-459D-46E5-B0F7-7C2C8617B46A

Q35890872-7EBCB49F-A8FE-48C6-9630-C85FB2CE2441

Q35890872-945C5A03-6D60-4446-A7E2-6D03FA249FF7

Q35890872-95C046D6-B38A-4218-B235-81B5459B42CB

P2860

Q35890872-0F17A261-0765-4A6D-BB03-65F5D45BFFB1

Q35890872-11EFF622-7007-41F6-854B-2183B6F55D24

Q35890872-11FDA6FD-F46B-40D6-AB4E-DC1D5518086D

Q35890872-15B6DA56-A0EF-4C63-B9CE-C4B184080793

Q35890872-19331F40-88B8-4A92-81B7-6E8A38C96701

Q35890872-2B9A0479-E959-42D9-B95D-622265999590

Q35890872-2C120721-1E9A-4EF8-83C1-0304F08FE034

Q35890872-2F6B168C-0637-4374-B95D-D316AF3A31DA

Q35890872-312E3095-20AA-4F23-8CCE-99FC81F3E0F6

Q35890872-437AF18C-B6F6-4701-B1CC-7FA0D61D98F0

P304

Q35890872-FF9C16D9-D36C-406B-B914-2357015BB877

P31

Q35890872-0AD327FA-CEA6-4222-ACF0-D6800CE8A334

P356

Q35890872-368E037E-49F0-42BA-B9D0-88DEEA662750

P407

Q35890872-782AFE81-56C6-456C-BCF5-8E0253E75D71

P433

Q35890872-15B826A5-8D86-4635-8507-5CF556C363C3

P478

Q35890872-FA9ED4F7-5A90-44E2-8159-2D79E5BB1C1C

P577

Q35890872-B5421907-71B8-4D83-A315-6F563F79125C

P5875

Q35890872-E2B0222C-26F1-4BC8-8DAC-EFA047DB078A

P698

Q35890872-CD8A353F-8D94-45BC-BA48-932DE4C79A48

P921

Q35890872-E3F5822D-957C-489F-90D7-94D1DF90B0CC

P932

Q35890872-888AAA79-E025-4D09-85F9-D0AE4013F3A8

P356

CIRCULATIONAHA.111.030296

P1433

P1476

9-cis retinoic acid promotes l ...... acid for secondary lymphedema.

@en

P2093

Alex K Wong

http://www.w3.org/2001/XMLSchema#string

Berenice Aguilar

http://www.w3.org/2001/XMLSchema#string

Chester J Koh

http://www.w3.org/2001/XMLSchema#string

Dongwon Choi

http://www.w3.org/2001/XMLSchema#string

Dongyun Yang

http://www.w3.org/2001/XMLSchema#string

Eun Kyung Park

http://www.w3.org/2001/XMLSchema#string

Ha Neul Lee

http://www.w3.org/2001/XMLSchema#string

Hee Kyoung Chung

http://www.w3.org/2001/XMLSchema#string

Inho Choi

http://www.w3.org/2001/XMLSchema#string

Jaehyuk Yoo

http://www.w3.org/2001/XMLSchema#string

P2860

Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor

Retinoic acid synthesis and signaling during early organogenesis

Retinoid X receptors: X-ploring their (patho)physiological functions

Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein.

p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis

An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype

Retinoic acid regulates endothelial cell proliferation during vasculogenesis

Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis

Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards

In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.

P304

872-882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.111.030296

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221775714

http://www.w3.org/2001/XMLSchema#string

P698

22275501

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

3327127

http://www.w3.org/2001/XMLSchema#string